View in EDS

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Saved in:
Bibliographic Details
Title: A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Authors: Tuscano JM; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.; Section of Hematology and Oncology, Veterans Administration Northern California Healthcare System, Mather, CA., Othman T; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Frankel P; Department of Biostatistics, City of Hope, Duarte, CA., Ruel C; Department of Biostatistics, City of Hope, Duarte, CA., Poh C; Department of Biostatistics, City of Hope, Duarte, CA., Herbert S; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA., Maverakis E; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA., Merleev AA; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA., Luxardi G; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA., Abedi M; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA., Ranganathan R; Division of Hematology and Oncology University of Southern California, Los Angeles, CA., Modi D; Division of Hematology and Oncology, Karmanos Cancer Institute, Detroit, MI., Zain J; Department of Biostatistics, City of Hope, Duarte, CA., Budde EL; Department of Biostatistics, City of Hope, Duarte, CA., Mei M; Department of Biostatistics, City of Hope, Duarte, CA., Rosenberg AS; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA., Hoeg RT; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA., Costello C; Division of Hematology and Oncology, University of California San Diego, La Jolla, CA., Foss FM; Section of Medical Oncology, Yale Cancer Center, New Haven, CT., William BM; Department of Hematology and Oncology, The Ohio State University, Columbus, OH., Holland HK; Department of Blood and Marrow Transplantation at Northside Hospital, Atlanta, GA., Sharon E; Department of Medicine, Dana-Farber Cancer Institute, Boston, MA., Streicher H; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Danilov AV; Department of Biostatistics, City of Hope, Duarte, CA., Newman E; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
Source: Blood advances [Blood Adv] 2026 Feb 24; Vol. 10 (4), pp. 1153-1162.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41213001
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tuscano+JM%22">Tuscano JM</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.; Section of Hematology and Oncology, Veterans Administration Northern California Healthcare System, Mather, CA.<br /><searchLink fieldCode="AU" term="%22Othman+T%22">Othman T</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Frankel+P%22">Frankel P</searchLink>; Department of Biostatistics, City of Hope, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Ruel+C%22">Ruel C</searchLink>; Department of Biostatistics, City of Hope, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Poh+C%22">Poh C</searchLink>; Department of Biostatistics, City of Hope, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Herbert+S%22">Herbert S</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Maverakis+E%22">Maverakis E</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Merleev+AA%22">Merleev AA</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Luxardi+G%22">Luxardi G</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Abedi+M%22">Abedi M</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Ranganathan+R%22">Ranganathan R</searchLink>; Division of Hematology and Oncology University of Southern California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Modi+D%22">Modi D</searchLink>; Division of Hematology and Oncology, Karmanos Cancer Institute, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Zain+J%22">Zain J</searchLink>; Department of Biostatistics, City of Hope, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Budde+EL%22">Budde EL</searchLink>; Department of Biostatistics, City of Hope, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Mei+M%22">Mei M</searchLink>; Department of Biostatistics, City of Hope, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Rosenberg+AS%22">Rosenberg AS</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Hoeg+RT%22">Hoeg RT</searchLink>; Division of Malignant Hematology Cellular Therapy and Transplantation, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Costello+C%22">Costello C</searchLink>; Division of Hematology and Oncology, University of California San Diego, La Jolla, CA.<br /><searchLink fieldCode="AU" term="%22Foss+FM%22">Foss FM</searchLink>; Section of Medical Oncology, Yale Cancer Center, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22William+BM%22">William BM</searchLink>; Department of Hematology and Oncology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Holland+HK%22">Holland HK</searchLink>; Department of Blood and Marrow Transplantation at Northside Hospital, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Sharon+E%22">Sharon E</searchLink>; Department of Medicine, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Streicher+H%22">Streicher H</searchLink>; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Danilov+AV%22">Danilov AV</searchLink>; Department of Biostatistics, City of Hope, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Newman+E%22">Newman E</searchLink>; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Feb 24; Vol. 10 (4), pp. 1153-1162.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41213001
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025016845
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1153
    Titles:
      – TitleFull: A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tuscano JM
      – PersonEntity:
          Name:
            NameFull: Othman T
      – PersonEntity:
          Name:
            NameFull: Frankel P
      – PersonEntity:
          Name:
            NameFull: Ruel C
      – PersonEntity:
          Name:
            NameFull: Poh C
      – PersonEntity:
          Name:
            NameFull: Herbert S
      – PersonEntity:
          Name:
            NameFull: Maverakis E
      – PersonEntity:
          Name:
            NameFull: Merleev AA
      – PersonEntity:
          Name:
            NameFull: Luxardi G
      – PersonEntity:
          Name:
            NameFull: Abedi M
      – PersonEntity:
          Name:
            NameFull: Ranganathan R
      – PersonEntity:
          Name:
            NameFull: Modi D
      – PersonEntity:
          Name:
            NameFull: Zain J
      – PersonEntity:
          Name:
            NameFull: Budde EL
      – PersonEntity:
          Name:
            NameFull: Mei M
      – PersonEntity:
          Name:
            NameFull: Rosenberg AS
      – PersonEntity:
          Name:
            NameFull: Hoeg RT
      – PersonEntity:
          Name:
            NameFull: Costello C
      – PersonEntity:
          Name:
            NameFull: Foss FM
      – PersonEntity:
          Name:
            NameFull: William BM
      – PersonEntity:
          Name:
            NameFull: Holland HK
      – PersonEntity:
          Name:
            NameFull: Sharon E
      – PersonEntity:
          Name:
            NameFull: Streicher H
      – PersonEntity:
          Name:
            NameFull: Danilov AV
      – PersonEntity:
          Name:
            NameFull: Newman E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 02
              Text: 2026 Feb 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1